IO Biotech, Inc. (IOBTQ) Free Cash Flow (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Free Cash Flow data on file, last reported at -$17.7 million in Q3 2025.

• Quarterly Free Cash Flow rose 11.97% year-over-year to -$17.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$81.1 million (up 5.37% YoY) and the FY2024 annual result came in at -$82.4 million, down 14.34% from the prior year.
• Free Cash Flow improved to -$17.7 million in Q3 2025, from -$19.9 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$3.9 million in Q1 2021 to a low of -$24.9 million in Q1 2024.
• A 5-year average of -$16.7 million and a median of -$17.8 million in 2024 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2021 — Free Cash Flow tumbled 522.56% — and 2022, when it jumped 33.16%.
• Tracing IOBTQ's Free Cash Flow over 5 years: stood at -$19.3 million in 2021, then surged by 33.16% to -$12.9 million in 2022, then plunged by 77.92% to -$22.9 million in 2023, then rose by 14.28% to -$19.6 million in 2024, then advanced by 10.09% to -$17.7 million in 2025.
• The last three Free Cash Flow figures came in at -$17.7 million (Q3 2025), -$19.9 million (Q2 2025), and -$23.9 million (Q1 2025), per Business Quant data.